PROGRAM CHAIRS

Ann Childress, MD
President, Center for Psychiatry and Behavioral Medicine
Clinical Associate Professor
Kirk Kerkorian School of Medicine at UNLV
Clinical Adjunct Associate Professor
Touro University Nevada College of Osteopathic Medicine
Las Vegas, Nevada
PRESENTER

Cecily Rook
Pediatric RN
Las Vegas, Nevada
PROGRAM OVERVIEW
These three podcasts are designed to support the educational needs of pediatricians involved in the diagnosis and management of ADHD. The first podcast will focus on how to recognize emotional dysregulation and executive dysfunction in children. It will also cover the impact of comorbidities on ADHD patient quality of life and outcomes, and developing management strategies that address ADHD symptoms and functional outcomes. The second podcast discusses the traditional dopamine-norepinephrine model and the emerging evidence for the role of serotonin in ADHD neurobiology. It highlights the implications of the interplay of dopamine, norepinephrine, and serotonin in the heterogeneity of treatment response. Finally, the third podcast will cover current pharmacologic options including stimulant and non-stimulant therapies and the residual symptoms of emotional dysregulation and executive dysfunction with existing therapies.
TARGET AUDIENCE
These educational activities are designed for primary care clinicians (including family medicine and internal medicine physicians), and pediatricians who diagnose and manage patients with ADHD across the lifespan.
LEARNING OBJECTIVES
Upon the completion of this program, attendees should be able to:
- Implement comprehensive evaluation techniques to identify the broader clinical features of ADHD and factors that influence functional impairment and disease burden
JOINT ACCREDITATION STATEMENT
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this enduring activity for a maximum of 0.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
NURSES (ANCC) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of 0.25 ANCC contact hours.
ACCME INNOVATION PARTNER
Med Learning Group (MLG) is proud to be recognized as an ACCME Innovation Partner, leading the way in simplifying CME for physicians. As an Innovation Partner, MLG will be working with the ACCME by submitting credits directly to CME Passport.
PHYSICIAN DISCLAIMER: Upon your acceptance in the evaluation and completion of this CME activity, Med Learning Group will share your completion information and certain personal details (eg, name, National Provider Identifier, birthdate MM/DD) with the ACCME for inclusion in your CME Passport transcript and, as applicable, reporting to certifying, licensing, or other regulatory authorities you specify.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS
| Faculty Member | Disclosures |
| Ann Childress, MD | Consulting Fees: Aardvark Therapeutics, Axsome Therapeutics, Cingulate, Corium, KemPharm, Lumos, Neurocentria, Otsuka, Supernus, Tris Pharma Advisory Boards: Alkermes, Bristol Myers Squibb, Collegium, Supernus Speakers Bureaus: Alora, Corium, Collegium, Noven, Otsuka, Supernus, Tris Pharma Contracted Research: Aardvark Therapeutics, Alkermes, Axsome, Bristol Myers Squibb, Cingulate, Corium, Syndeio Biosciences, Collegium, Lilly, Lumos Pharma, Neurocentria, Noven, Otsuka, Supernus, Suven Life Sciences, Tris Pharma, Vanda Fees for Non-CE Services: Alora, Cingulate, Corium, Collegium, Otsuka, Supernus |
| Cecily Rook, RN | Has nothing to disclose |
All relevant financial relationships have been mitigated.
Content Review
The content of this activity was independently peer reviewed by a physician and nurse reviewer.
Individuals in Control of the Content of the Activity
The individuals in control of the content of this activity have reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CE activity:
- Andrew Grzybowski, CEO of Med Learning Group, has nothing to disclose.
- Lauren Welch, COO of Med Learning Group, has nothing to disclose.
- Tom Bregartner, MBA, VP of Outcomes and Accreditation for Med Learning Group, has nothing to disclose.
- Vaidehee Deshpande, PhD, Medical Director for Med Learning Group, has nothing to disclose.
- A medical reviewer from CME Peer Review LLC, has nothing to disclose.
- Nicholas Applyrs, DO, has nothing to disclose.
- Ana Maria Albino, Senior Program Manager for Med Learning Group, has nothing to disclose.
- Jessica Feygin-Samuels, Program Manager for Med Learning Group, has nothing to disclose.
- Evan Hooper, Program Coordinator for Med Learning Group, has nothing to disclose.
- Aimee Meissner, Accreditation and Outcomes Manager for Med Learning Group, has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CE credit for this activity. In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation. Your certificate will be provided as a downloadable file.
DISCLAIMER
Med Learning Group makes every effort to develop CE activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CE questions, please contact Med Learning Group at [email protected]
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Expert staff will be glad to assist you with any special needs (eg, physical, dietary, etc). Please contact Med Learning Group prior to participating at [email protected]
Please listen to the podcast below:
RELEASED DATE: November 10, 2026
EXPIRATION DATE: November 10, 2027

Copyright © 2026 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.
PROGRAM CHAIRS

Ann Childress, MD
President, Center for Psychiatry and Behavioral Medicine
Clinical Associate Professor
Kirk Kerkorian School of Medicine at UNLV
Clinical Adjunct Associate Professor
Touro University Nevada College of Osteopathic Medicine
Las Vegas, Nevada
PRESENTER

Cecily Rook
Pediatric RN
Las Vegas, Nevada
PROGRAM OVERVIEW
These three podcasts are designed to support the educational needs of pediatricians involved in the diagnosis and management of ADHD. The first podcast will focus on how to recognize emotional dysregulation and executive dysfunction in children. It will also cover the impact of comorbidities on ADHD patient quality of life and outcomes, and developing management strategies that address ADHD symptoms and functional outcomes. The second podcast discusses the traditional dopamine-norepinephrine model and the emerging evidence for the role of serotonin in ADHD neurobiology. It highlights the implications of the interplay of dopamine, norepinephrine, and serotonin in the heterogeneity of treatment response. Finally, the third podcast will cover current pharmacological options including stimulant and non-stimulant therapies and the residual symptoms of emotional dysregulation and executive dysfunction with existing therapies.
TARGET AUDIENCE
These educational activities are designed for primary care clinicians (including family medicine and internal medicine physicians), and pediatricians who diagnose and manage patients with ADHD across the lifespan.
LEARNING OBJECTIVES
Upon the completion of this program, attendees should be able to:
- Identify the neurobiological underpinnings of ADHD including the role of and interplay between dopamine, norepinephrine, and serotonin
JOINT ACCREDITATION STATEMENT
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this enduring activity for a maximum of 0.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
NURSES (ANCC) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of 0.25 ANCC contact hours.
ACCME INNOVATION PARTNER
Med Learning Group (MLG) is proud to be recognized as an ACCME Innovation Partner, leading the way in simplifying CME for physicians. As an Innovation Partner, MLG will be working with the ACCME by submitting credits directly to CME Passport.
PHYSICIAN DISCLAIMER: Upon your acceptance in the evaluation and completion of this CME activity, Med Learning Group will share your completion information and certain personal details (eg, name, National Provider Identifier, birthdate MM/DD) with the ACCME for inclusion in your CME Passport transcript and, as applicable, reporting to certifying, licensing, or other regulatory authorities you specify.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS
| Faculty Member | Disclosures |
| Ann Childress, MD | Consulting Fees: Aardvark Therapeutics, Axsome Therapeutics, Cingulate, Corium, KemPharm, Lumos, Neurocentria, Otsuka, Supernus, Tris Pharma Advisory Boards: Alkermes, Bristol Myers Squibb, Collegium, Supernus Speakers Bureaus: Alora, Corium, Collegium, Noven, Otsuka, Supernus, Tris Pharma Contracted Research: Aardvark Therapeutics, Alkermes, Axsome, Bristol Myers Squibb, Cingulate, Corium, Syndeio Biosciences, Collegium, Lilly, Lumos Pharma, Neurocentria, Noven, Otsuka, Supernus, Suven Life Sciences, Tris Pharma, Vanda Fees for Non-CE Services: Alora, Cingulate, Corium, Collegium, Otsuka, Supernus |
| Cecily Rook, RN | Has nothing to disclose |
All relevant financial relationships have been mitigated.
Content Review
The content of this activity was independently peer reviewed by a physician and nurse reviewer.
Individuals in Control of the Content of the Activity
The individuals in control of the content of this activity have reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CE activity:
- Andrew Grzybowski, CEO of Med Learning Group, has nothing to disclose.
- Lauren Welch, COO of Med Learning Group, has nothing to disclose.
- Tom Bregartner, MBA, VP of Outcomes and Accreditation for Med Learning Group, has nothing to disclose.
- Vaidehee Deshpande, PhD, Medical Director for Med Learning Group, has nothing to disclose.
- A medical reviewer from CME Peer Review LLC, has nothing to disclose.
- Nicholas Applyrs, DO, has nothing to disclose.
- Ana Maria Albino, Senior Program Manager for Med Learning Group, has nothing to disclose.
- Jessica Feygin-Samuels, Program Manager for Med Learning Group, has nothing to disclose.
- Evan Hooper, Program Coordinator for Med Learning Group, has nothing to disclose.
- Aimee Meissner, Accreditation and Outcomes Manager for Med Learning Group, has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CE credit for this activity. In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation. Your certificate will be provided as a downloadable file.
DISCLAIMER
Med Learning Group makes every effort to develop CE activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CE questions, please contact Med Learning Group at [email protected]
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Expert staff will be glad to assist you with any special needs (eg, physical, dietary, etc). Please contact Med Learning Group prior to participating at [email protected]
Please listen to the podcast below:
RELEASED DATE: November 10, 2026
EXPIRATION DATE: November 10, 2027

Copyright © 2026 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.
PROGRAM CHAIRS

Ann Childress, MD
President, Center for Psychiatry and Behavioral Medicine
Clinical Associate Professor
Kirk Kerkorian School of Medicine at UNLV
Clinical Adjunct Associate Professor
Touro University Nevada College of Osteopathic Medicine
Las Vegas, Nevada
PRESENTER

Cecily Rook
Pediatric RN
Las Vegas, Nevada
PROGRAM OVERVIEW
These three podcasts are designed to support the educational needs of pediatricians involved in the diagnosis and management of ADHD. The first podcast will focus on how to recognize emotional dysregulation and executive dysfunction in children. It will also cover the impact of comorbidities on ADHD patient quality of life and outcomes, and developing management strategies that address ADHD symptoms and functional outcomes. The second podcast discusses the traditional dopamine-norepinephrine model and the emerging evidence for the role of serotonin in ADHD neurobiology. It highlights the implications of the interplay of dopamine, norepinephrine, and serotonin in the heterogeneity of treatment response. Finally, the third podcast will cover current pharmacological options including stimulant and non-stimulant therapies and the residual symptoms of emotional dysregulation and executive dysfunction with existing therapies.
TARGET AUDIENCE
These educational activities are designed for primary care clinicians (including family medicine and internal medicine physicians), and pediatricians who diagnose and manage patients with ADHD across the lifespan.
LEARNING OBJECTIVES
Upon the completion of this program, attendees should be able to:
- Apply clinical evidence for current and emerging ADHD pharmacotherapies, including their strengths and limitations, to inform treatment selection and comprehensive disease management of ADHD
JOINT ACCREDITATION STATEMENT
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this enduring activity for a maximum of 0.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
NURSES (ANCC) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of 0.25 ANCC contact hours.
ACCME INNOVATION PARTNER
Med Learning Group (MLG) is proud to be recognized as an ACCME Innovation Partner, leading the way in simplifying CME for physicians. As an Innovation Partner, MLG will be working with the ACCME by submitting credits directly to CME Passport.
PHYSICIAN DISCLAIMER: Upon your acceptance in the evaluation and completion of this CME activity, Med Learning Group will share your completion information and certain personal details (eg, name, National Provider Identifier, birthdate MM/DD) with the ACCME for inclusion in your CME Passport transcript and, as applicable, reporting to certifying, licensing, or other regulatory authorities you specify.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS
| Faculty Member | Disclosures |
| Ann Childress, MD | Consulting Fees: Aardvark Therapeutics, Axsome Therapeutics, Cingulate, Corium, KemPharm, Lumos, Neurocentria, Otsuka, Supernus, Tris Pharma Advisory Boards: Alkermes, Bristol Myers Squibb, Collegium, Supernus Speakers Bureaus: Alora, Corium, Collegium, Noven, Otsuka, Supernus, Tris Pharma Contracted Research: Aardvark Therapeutics, Alkermes, Axsome, Bristol Myers Squibb, Cingulate, Corium, Syndeio Biosciences, Collegium, Lilly, Lumos Pharma, Neurocentria, Noven, Otsuka, Supernus, Suven Life Sciences, Tris Pharma, Vanda Fees for Non-CE Services: Alora, Cingulate, Corium, Collegium, Otsuka, Supernus |
| Cecily Rook, RN | Has nothing to disclose |
All relevant financial relationships have been mitigated.
Content Review
The content of this activity was independently peer reviewed by a physician and nurse reviewer.
Individuals in Control of the Content of the Activity
The individuals in control of the content of this activity have reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CE activity:
- Andrew Grzybowski, CEO of Med Learning Group, has nothing to disclose.
- Lauren Welch, COO of Med Learning Group, has nothing to disclose.
- Tom Bregartner, MBA, VP of Outcomes and Accreditation for Med Learning Group, has nothing to disclose.
- Vaidehee Deshpande, PhD, Medical Director for Med Learning Group, has nothing to disclose.
- A medical reviewer from CME Peer Review LLC, has nothing to disclose.
- Nicholas Applyrs, DO, has nothing to disclose.
- Ana Maria Albino, Senior Program Manager for Med Learning Group, has nothing to disclose.
- Jessica Feygin-Samuels, Program Manager for Med Learning Group, has nothing to disclose.
- Evan Hooper, Program Coordinator for Med Learning Group, has nothing to disclose.
- Aimee Meissner, Accreditation and Outcomes Manager for Med Learning Group, has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CE credit for this activity. In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation. Your certificate will be provided as a downloadable file.
DISCLAIMER
Med Learning Group makes every effort to develop CE activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CE questions, please contact Med Learning Group at [email protected]
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Expert staff will be glad to assist you with any special needs (eg, physical, dietary, etc). Please contact Med Learning Group prior to participating at [email protected]
Please listen to the podcast below:
RELEASED DATE: November 10, 2026
EXPIRATION DATE: November 10, 2027

Copyright © 2026 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.